Lidia Haratynowicz

Lidia Haratynowicz is the BPM Evidence Delivery Operations Director at AstraZeneca, where they currently lead evidence study teams focused on a broad portfolio of evidence activities. They bring extensive experience in clinical studies and trials, specifically in phase II and III clinical drug studies across oncology, epilepsy, and diabetes. Previously, Lidia held various roles at AstraZeneca, including Associate Director of Study Management and Clinical Development Manager, and worked as a Clinical Research Associate at PAREXEL. Lidia began their career in clinical practice as a veterinary doctor before transitioning to the clinical research industry. They have pursued further education in motivational interviewing and coaching alongside their veterinary degree.